经全脑数字减影血管造影术引导神经介入联合阿替普酶治疗缺血性脑血管病患者的疗效

doi:10.3969/j.issn.1671-7171.2025.09.031

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1274 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】 To investigate the therapeutic effect of digital subtraction angiography(DSA)-guided neurointervention combined with alteplase in patients with ischemic cerebrovascular disease(ISCV).【Methods】 A total of 102 patients with ISCV were randomly assigned into the control group and the observation group, with 51 cases in each. The control group received intravenous thrombolysis with alteplase, while the observation group received DSA-guided neurointervention combined with alteplase. Clinical efficacy, vascular endothelial function, neurological function [National Institutes of Health Stroke Scale(NIHSS) score], quality of life [Activities of Daily Living(ADL) score], cerebral hemodynamic parameters, and incidence of complications were compared between the two groups before treatment and 12 weeks after treatment.【Results】 The total effective rate in the observation group was higher than that in the control group(P<0.05). After treatment, brachial-ankle pulse wave velocity(ba-PWV) and ankle-brachial index(ABI) levels in the observation group were lower, while flow-mediated dilation(FMD) was higher compared with the control group(P<0.05). The NIHSS score in the observation group was lower than that in the control group, and the ADL score in the observation group was higher than that in the control group(P<0.05). Peak systolic velocity(Vs) and end-diastolic velocity(Vd) in the observation group were lower than those in the control group(P<0.05). The overall incidence of complications was also lower in the observation group compared to the control group(P<0.05).【Conclusion】 DSA-guided neurointervention combined with alteplase has a superior therapeutic effect in ISCV patients. It can improve vascular endothelial function and neurological function, enhance quality of life, and reduce the incidence of complications.

Key words： Brain Ischemia Cerebral Angiography Endovascular Procedures Tissue Plasminogen
Activator

Received: 18 November 2024

PACS:

R743

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	JIANG Zhifeng
	LI Gen
	ZHENG Xingxing
	et al

Cite this article:

JIANG Zhifeng,LI Gen,ZHENG Xingxing, et al. Therapeutic Effect of Digital Subtraction Angiography Guided Neurointervention Combined with Alteplase in Patients with Ischemic Cerebrovascular Disease[J]. JOURNAL OF CLINICAL RESEARCH, 2025, 42(9): 1598-1600.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2025.09.031 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2025/V42/I9/1598

[1] 陆军,王大明. 聚焦缺血性脑血管病介入治疗新进展[J].中华外科杂志,2021,59(3):192-195.
[2] 林道云,陈高俊,华如鹏,等. 经全脑血管造影术引导神经介入治疗对缺血性脑血管病的疗效分析[J].湖南师范大学学报(医学版),2021,18(6):35-38.
[3] 张紫寅,王德全,段彬,等. 经桡动脉和股动脉路径行全脑血管造影和颈动脉支架置入术患者辐射剂量及照射时间研究[J].脑与神经疾病杂志,2020,28(4):203-207.
[4] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组,中华医学会神经病学分会神经血管介入协作组. 中国缺血性脑血管病血管内介入诊疗指南2015[J].中华神经科杂志,2015,48(10):830-837.
[5] 黄敬,何玮,张良兵,等. 血管内支架介入在缺血性脑卒中治疗中的价值研究[J].实用心脑肺血管病杂志,2014,22(5):54-56.
[6] 巫嘉陵,安中平,王世民,等. 脑卒中患者日常生活活动能力量表的信度与效度研究[J].中国现代神经疾病杂志,2009,9(5):464-468.
[7] 赵士军,刘世雄,宣海龙. 急性缺血性脑卒中血管内介入治疗效果及对IGF-1、HCY、Lp-PLA2的影响[J].分子诊断与治疗杂志,2023,15(8):1344-1347.
[8] 杜志刚,伊红丽,王宇,等. 丁苯酞联合阿替普酶治疗缺血性脑血管病的疗效及其对颈动脉粥样硬化程度和血清脂质过氧化物、血栓前体蛋白水平的影响[J].临床内科杂志,2023,40(2):129-130.
[9] 朱斌. 神经介入联合阿替普酶治疗急性缺血性脑卒中的临床疗效及预后质量[J].国际生物医学工程杂志,2022,45(5):419.
[10] 宗彦武,蔡柳燕,张岩. 神经介入联合阿加曲班对急性缺血性脑卒中患者血清FIB,D-D表达水平的影响[J].卒中与神经疾病,2022,29(4):365-368.
[11] 付华文,李光建. 数字减影血管造影联合神经介入溶栓术治疗缺血性脑血管疾病临床效果观察[J].实用医院临床杂志,2019,16(6):178-182.
[12] 常馨,王月,杨勇. DSA引导下神经介入溶栓术治疗老年缺血性脑卒中效果及对血管内皮功能的影响[J].中国老年学杂志,2021,41(6):1148-1151.
[13] 李雯,陈朔华,赵剑秋,等. 颈动脉斑块和低踝臂指数联合作用增加老年人缺血性心脑血管事件的发生风险[J].中华心血管病杂志,2021,49(3):263-268.
[14] 丁冀,许敏,陆学胜. 支架置入术对颈动脉粥样硬化病人脑血流动力学和神经认知功能的影响[J].中西医结合心脑血管病杂志,2020,18(8):1331-1333.